NeuroVasc Technologies develops catheter-based systems for the treatment of neurovascular diseases, specifically targeting ischemic stroke through mechanical thrombectomy and aspiration techniques. Their technology enhances patient outcomes by providing effective and minimally invasive options for removing blood clots from the brain.
Funding
$43M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Ischemic stroke treatment often requires invasive procedures to remove blood clots from the brain, posing risks and demanding specialized equipment and expertise. Current catheter-based systems may not always be effective or efficient in restoring blood flow, potentially leading to incomplete clot removal and prolonged procedure times.
Solution
NeuroVasc Technologies develops a portfolio of catheter-based technologies designed to improve the treatment of neurovascular diseases, with a focus on ischemic stroke. Their systems facilitate mechanical thrombectomy and aspiration, offering minimally invasive options for removing blood clots and restoring blood flow in the brain. The company's devices aim to enhance the effectiveness and efficiency of clot removal, potentially leading to improved patient outcomes and reduced procedure times. NeuroVasc's technologies are available in multiple countries, expanding access to advanced stroke treatment options.
Target Audience
The primary target audience includes neurovascular surgeons, interventional radiologists, and hospitals specializing in stroke treatment and neurovascular interventions.
Features
- Retriever for Mechanical Thrombectomy
- Micro and Intermediate Catheters for navigation and access to target vessels
- Aspiration Catheter for direct clot removal
- Designed for efficient and effective clot retrieval
- Broad portfolio of catheter-based technologies